Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist approved for weight management and type 2 diabetes. It works by binding to GLP-1 receptors to reduce appetite, slow gastric emptying, and improve insulin sensitivity. It is available under brand names Ozempic® (diabetes) and Wegovy® (weight management), as well as through licensed compounding pharmacies as a lower-cost alternative.
Prescription requirement
Semaglutide requires a prescription from a licensed healthcare provider. Online telehealth platforms connect patients with licensed clinicians who evaluate eligibility based on BMI, medical history, and health goals. Compounded semaglutide — the lower-cost version available through telehealth — uses the same active ingredient as brand-name formulations but is not FDA-approved as a finished drug product.
Telehealth providers compared
PeptideComparison scores telehealth providers on five criteria: price, reviews, shipping speed, availability, and COA/pharmacy quality. Unlike raw peptide vendors, telehealth providers are evaluated on the regulatory standing of their compounding pharmacy, clinician oversight, and transparency of their dispensing process rather than third-party HPLC documentation.
What to look for in a provider
Key factors when choosing a semaglutide telehealth provider include: whether they use an FDA-registered compounding pharmacy, upfront all-inclusive pricing (no hidden fees), clear titration protocols, licensed prescriber oversight, and responsive support. Watch for providers who increase prices as your dose increases — flat-rate pricing models (like Eden's) provide more predictable costs.
See all Semaglutide vendors ranked
PeptideComparison independently scores every vendor on COA quality (weighted 2×), price, reviews, shipping, and availability. Click below to see the full ranked list filtered to Semaglutide vendors.
View Semaglutide vendor rankings →